Skip to content

Oral solution of tipranavir/ritonavir shows promise for treatment-experienced kids

Anal cancer increases in French HIV cohort, despite use of antiretroviral therapy

Two-class ART just as good as three-class in the long-term, and has fewer side-effects

Brain problems and peripheral neuropathy under-diagnosed in Asia and the Pacific

Sexual risk-taking may be associated with MRSA in HIV-positive individuals

Prophylaxis guided by CD4 cell count a 'beacon of hope' for patients in poorer countries with no access to HIV treatment

Duration of HIV infection and duration of HIV therapy use risk factors for bone disease

Genetics associated with risk of severe allergic reaction to nevirapine

Lowered AZT dose for low weight patients 'effective and reduces toxicity'